Enliven Therapeutics (ELVN) Share-based Compensation (2019 - 2026)
Enliven Therapeutics' Share-based Compensation came in at $13.92 million for Q2 2026, up 80.2% from $7.72 million a year earlier and up 88.1% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Share-based Compensation (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Enliven Therapeutics reported Share-based Compensation of $40.81 million, up 63.0% year-over-year; for FY2025, it was $34.02 million, up 68.6% from FY2024.
- Share-based Compensation has increased in each of the last three years, with a five-year compound annual growth rate of 72.4% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $20.17 million in FY2024 (+56.2%), $12.91 million in FY2023 (+304.7%), $3.19 million in FY2022 (-17.0%) and $3.85 million in FY2021 (+72.3%).
- The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q1 2019.
- Year-over-year, Share-based Compensation has increased for 14 consecutive quarters, with growth averaging 60.7% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q2 2023 (growth of 498.4%), and the weakest in Q1 2022 (a decline of 30.9%).
- Business Quant data shows ELVN's Share-based Compensation at $7.4 million (Q1 2026), $12.31 million (Q4 2025) and $7.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Enliven Therapeutics | 2.77 Bn | 482.20 Mn | - | 13.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.92 Mn |
| Mar 31, 2026 | 7.40 Mn |
| Dec 31, 2025 | 12.31 Mn |
| Sep 30, 2025 | 7.19 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Mar 31, 2025 | 6.80 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Sep 30, 2024 | 5.18 Mn |
| Jun 30, 2024 | 5.14 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Dec 31, 2023 | 3.06 Mn |
| Sep 30, 2023 | 3.40 Mn |
| Jun 30, 2023 | 4.20 Mn |
| Mar 31, 2023 | 2.26 Mn |
| Dec 31, 2022 | 735,000.00 |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 701,000.00 |
| Mar 31, 2022 | 654,000.00 |
| Dec 31, 2021 | 978,000.00 |
| Sep 30, 2021 | 1.00 Mn |
API Access
Enliven Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();